Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1698077 |
394 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//SHIKONIN | 32432 |
846 | 2 | CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN | 11845 |
1709 | 2 | SHIKONIN//NAPHTHOQUINONE//PLUMBAGIN | 6976 |
2704 | 2 | DUOCARMYCIN//ADEPT//MINOR GROOVE BINDER | 3575 |
2831 | 2 | ENEDIYNE//BERGMAN CYCLIZATION//LIDAMYCIN | 3229 |
2954 | 2 | DT DIAPHORASE//NQO1//MENADIONE | 2898 |
3286 | 2 | PHENOTHIAZINE//NON ANTIBIOTICS//BENZOAPHENOTHIAZINES | 2009 |
4054 | 2 | ORAL TUMOR CELLS//DENT PHARMACOL//DIAGNOST THER EUT SCI | 743 |
4132 | 2 | CI 958//SR271425//THIOXANTHONE | 648 |
4265 | 2 | ACTIVITAS NERVOSA SUPERIOR//DIBENZOB ETHIEPINE//ZALTOPROFEN | 509 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CARDIOTOXICITY | authKW | 468849 | 3% | 48% | 1014 |
2 | ANTHRACYCLINES | authKW | 314024 | 2% | 42% | 766 |
3 | SHIKONIN | authKW | 177423 | 1% | 80% | 230 |
4 | DOXORUBICIN | authKW | 177127 | 3% | 17% | 1103 |
5 | NAPHTHOQUINONE | authKW | 154405 | 1% | 49% | 325 |
6 | PLUMBAGIN | authKW | 129293 | 1% | 73% | 183 |
7 | BETA LAPACHONE | authKW | 116120 | 0% | 87% | 138 |
8 | ENEDIYNE | authKW | 104747 | 0% | 69% | 157 |
9 | NQO1 | authKW | 79687 | 1% | 46% | 179 |
10 | DEXRAZOXANE | authKW | 75024 | 0% | 69% | 112 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Chemistry, Organic | 55107 | 20% | 1% | 6354 |
2 | Chemistry, Medicinal | 32681 | 10% | 1% | 3250 |
3 | Pharmacology & Pharmacy | 23455 | 18% | 1% | 5735 |
4 | Oncology | 21232 | 15% | 1% | 4886 |
5 | Chemistry, Multidisciplinary | 13992 | 16% | 0% | 5181 |
6 | Biochemistry & Molecular Biology | 7208 | 16% | 0% | 5349 |
7 | Biophysics | 2564 | 4% | 0% | 1399 |
8 | Toxicology | 1475 | 3% | 0% | 915 |
9 | Crystallography | 727 | 2% | 0% | 628 |
10 | Integrative & Complementary Medicine | 453 | 1% | 0% | 197 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DENT PHARMACOL | 16681 | 0% | 15% | 113 |
2 | MODIFIED ANTIBIOT | 14209 | 0% | 67% | 22 |
3 | UNIT MYCOBACTERIOL | 12840 | 0% | 40% | 33 |
4 | DIAGNOST THER EUT SCI | 11569 | 0% | 25% | 49 |
5 | ROCKY MT CANC REHABIL | 10162 | 0% | 50% | 21 |
6 | HRICHTUNG PHARMAZEUT CHEM | 9635 | 0% | 76% | 13 |
7 | BIOORGAN MED CHEM S | 9215 | 0% | 48% | 20 |
8 | TOXICOL CANC BIOL GRP | 9000 | 0% | 47% | 20 |
9 | ETNOFARMACOL IDE | 8068 | 0% | 56% | 15 |
10 | QUIM SINTET HETEROCICL | 7854 | 0% | 90% | 9 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF ANTIBIOTICS | 38012 | 2% | 8% | 520 |
2 | ANTI-CANCER DRUG DESIGN | 34112 | 0% | 24% | 149 |
3 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 22582 | 1% | 6% | 424 |
4 | CANCER TREATMENT REPORTS | 18697 | 1% | 9% | 208 |
5 | INVESTIGATIONAL NEW DRUGS | 14765 | 1% | 8% | 201 |
6 | TETRAHEDRON LETTERS | 11686 | 3% | 1% | 1004 |
7 | JOURNAL OF ORGANIC CHEMISTRY | 8839 | 2% | 1% | 733 |
8 | BIOCHEMICAL PHARMACOLOGY | 8593 | 1% | 2% | 423 |
9 | BIOORGANIC & MEDICINAL CHEMISTRY | 8591 | 1% | 3% | 357 |
10 | ACTIVITAS NERVOSA SUPERIOR | 8237 | 0% | 10% | 91 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARDIOTOXICITY | 468849 | 3% | 48% | 1014 | Search CARDIOTOXICITY | Search CARDIOTOXICITY |
2 | ANTHRACYCLINES | 314024 | 2% | 42% | 766 | Search ANTHRACYCLINES | Search ANTHRACYCLINES |
3 | SHIKONIN | 177423 | 1% | 80% | 230 | Search SHIKONIN | Search SHIKONIN |
4 | DOXORUBICIN | 177127 | 3% | 17% | 1103 | Search DOXORUBICIN | Search DOXORUBICIN |
5 | NAPHTHOQUINONE | 154405 | 1% | 49% | 325 | Search NAPHTHOQUINONE | Search NAPHTHOQUINONE |
6 | PLUMBAGIN | 129293 | 1% | 73% | 183 | Search PLUMBAGIN | Search PLUMBAGIN |
7 | BETA LAPACHONE | 116120 | 0% | 87% | 138 | Search BETA+LAPACHONE | Search BETA+LAPACHONE |
8 | ENEDIYNE | 104747 | 0% | 69% | 157 | Search ENEDIYNE | Search ENEDIYNE |
9 | NQO1 | 79687 | 1% | 46% | 179 | Search NQO1 | Search NQO1 |
10 | DEXRAZOXANE | 75024 | 0% | 69% | 112 | Search DEXRAZOXANE | Search DEXRAZOXANE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 3 |